Home Cart 0 Sign in  

[ CAS No. 50525-27-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 50525-27-4
Chemical Structure| 50525-27-4
Structure of 50525-27-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 50525-27-4 ]

Related Doc. of [ 50525-27-4 ]

Alternatived Products of [ 50525-27-4 ]

Product Details of [ 50525-27-4 ]

CAS No. :50525-27-4 MDL No. :MFCD00149670
Formula : C30H36Cl2N6O6Ru Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 748.62 Pubchem ID :-
Synonyms :

Calculated chemistry of [ 50525-27-4 ]

Physicochemical Properties

Num. heavy atoms : 45
Num. arom. heavy atoms : 36
Fraction Csp3 : 0.0
Num. rotatable bonds : 3
Num. H-bond acceptors : 12.0
Num. H-bond donors : 6.0
Molar Refractivity : 172.4
TPSA : 132.72 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.7 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 3.05
Log Po/w (WLOGP) : 7.42
Log Po/w (MLOGP) : -2.97
Log Po/w (SILICOS-IT) : 2.55
Consensus Log Po/w : 2.01

Druglikeness

Lipinski : 3.0
Ghose : None
Veber : 0.0
Egan : 2.0
Muegge : 3.0
Bioavailability Score : 0.17

Water Solubility

Log S (ESOL) : -6.8
Solubility : 0.000119 mg/ml ; 0.00000016 mol/l
Class : Poorly soluble
Log S (Ali) : -5.5
Solubility : 0.00235 mg/ml ; 0.00000314 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -4.16
Solubility : 0.0524 mg/ml ; 0.00007 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 4.03

Safety of [ 50525-27-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 50525-27-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 50525-27-4 ]

[ 50525-27-4 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 50525-27-4 ]
  • [ CAS Unavailable ]
  • [ 15635-95-7 ]
YieldReaction ConditionsOperation in experiment
82% In lithium hydroxide monohydrate at 20℃; 2.1 Synthesis and structure characterization of complex 2 General procedure: [Ru(bpy)3]Cl2·6H2O (1.0110 g, 1.350 mmol) was purchased from Adamas Reagent. Ltd. and dissolved in ethylene glycol. An aqueous solution of excess Na[BF4] (2.0124 g, 18.330 mmol) was slowly added into the reaction mixture under stirring, resulting in a red suspension. The suspension was then filtrated and the resulting precipitate was washed with deionized water and dried under vacuum at 70 °C overnight. The crude product was purified by column chromatography on silica gel (200-300 mesh) with dichloromethane/methanol (v/v = 10:1) as the eluent, yielding a red powder (0.5311 g, 0.715 mmol). Yield: 53%.
61% In lithium hydroxide monohydrate Cooling with ice; Inert atmosphere;
In lithium hydroxide monohydrate excess NaClO4; crystn.;
In lithium hydroxide monohydrate with excess of NaClO4; recrystd. three times from H2O-ethanol mixture (4:1) and dried under vac. at 60°C for 48 h;
In lithium hydroxide monohydrate with excess of NaClO4; the crystals were washed with H2O, recrystd. once from ethanol and twice from acetonitrile and dried under vac. at 90°C for 24 h;
With Ag2SO4 In lithium hydroxide monohydrate byproducts: AgCl; Ag2SO4 was added to aq. soln. of chloride complex, filtered, satd. NaClO4 soln. was added;; recrystd. from water;;
In lithium hydroxide monohydrate sample metathesis in excess Na-salt soln.; crystals washing (H2O) recrystn. (EtOH, MeCN), vac. drying at 90°C for 24 h;

Same Skeleton Products
Historical Records